Searched for
SMALL MOLECULE DRUGS
India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- A flash of blue light just solved one of drug development's biggest puzzles, here's all about itScientists at the University of Münster report a major advance in light-powered chemistry for housane molecules on May 20, 2026. Using phot...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Obesity drug market to gain as Indians pop the pill and Chinese bring moreIndia's obesity treatment market is set for a major shift by year-end. A wave of oral GLP1 weight-loss pills, including those from China, w...
- Anthem BioSciences shares jump 4% as Citi initiates with Buy rating. Check target, upside potentialShares of Anthem BioSciences rose after Citi initiated coverage with a Buy rating and a target price of ₹870, implying over 20% upside. Ana...
- US Stocks | Kailera soars over 60% in Nasdaq debut as weight-loss drug race heats upKailera Therapeutics shares surged 62.5% in their Nasdaq debut after raising $625 million in a U.S. IPO priced at the top end of its range....
- Takeda deepens AI drug discovery push with $1.7 billion Iambic dealIambic and Takeda Pharmaceutical have formed a multi-year partnership valued at over $1.7 billion. This collaboration will leverage artific...
- Nvidia-backed AI startup SandboxAQ creates new data to speed up drug discoverySandboxAQ, an AI startup originating from Alphabet's Google and backed by Nvidia, has released a substantial dataset to accelerate drug dis...
- Glenmark forms alliance with Ichnos to develop anti-cancer drugsGlenmark Pharmaceuticals and Ichnos Sciences have formed an alliance called Ichnos Glenmark Innovation (IGI) to accelerate cancer drug disc...
- NCBS scientists identify 33 molecules that could be used to treat virus patientsA group of scientists led by Professor R. Sowdhamini at NCBS has identified the 33 small molecules from a database of over 3,30,000 small m...
- Artificial, small molecules may help tackle heart attack & other cardiovascular disordersA 2018 Lancet study says, India accounts for about a fifth of cardiovascular deaths globally.
- Drug used for hypertension may help prevent type 1 diabetesThe drug, methyldopa, has been used for over 50 years to treat high blood pressure in pregnant women and children
- System to deliver drugs to individual cells developedThe major hurdle has been that as these local cues are not consistent between cells; one needs systems that respond to multiple such cues.
- New test to spot what makes a good drugA new test could revolutionise the discovery of new prescription drugs by determining which drugs are unlikely to work at an early stage.
- Anti-diabetes Molecules: Connexios inks licence deal with German pharma major Boehringer IngelheimFor Connexios, this sale of its anti-diabetes molecules to Boehringer Ingelheim is the first out-licensing deal by an Indian life-sciences ...
- Aurigene tech enters collaboration with Forest LabsThe company has also entered into a discovery collaboration with biotechnology company Merck Serono International
Load More
